Editorials

Unlocking the therapeutic potential of targeting MALT1 in B-cell acute lymphoblastic leukemia

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA 44195
Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA 44195; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA 44195
Haematologica Early view Nov 2, 2023 https://doi.org/10.3324/haematol.2023.284237